LT3484863T - Cikliniai amidai, kaip kalio kanalų atvėrimo agentai - Google Patents

Cikliniai amidai, kaip kalio kanalų atvėrimo agentai

Info

Publication number: LT3484863T
Authority: LT; Lithuania
Prior art keywords: potassium channel; channel openers; cyclic amides; amides; cyclic
Prior art date: 2017-02-28

Application number

LTEP18707374.7T

Other languages

English (en)

Inventor

Michael Bös

Original Assignee

Acousia Therapeutics Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-02-28

Filing date

2018-02-27

Publication date

2020-07-27

2018-02-27 Application filed by Acousia Therapeutics Gmbh filed Critical Acousia Therapeutics Gmbh

2020-07-27 Publication of LT3484863T publication Critical patent/LT3484863T/lt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/26—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/43—Y being a hetero atom
- C07C323/44—X or Y being nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/63—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Cosmetics (AREA)
Fertilizers (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

LTEP18707374.7T 2017-02-28 2018-02-27 Cikliniai amidai, kaip kalio kanalų atvėrimo agentai LT3484863T (lt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP17158326.3A EP3366683A1 (en)	2017-02-28	2017-02-28	Cyclic amides, acteamides and ureas useful as potassium channel openers
PCT/EP2018/054820 WO2018158256A2 (en)	2017-02-28	2018-02-27	Novel compounds useful as potassium channel openers

Publications (1)

Publication Number	Publication Date
LT3484863T true LT3484863T (lt)	2020-07-27

Family

ID=58192162

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
LTEP18707374.7T LT3484863T (lt)	2017-02-28	2018-02-27	Cikliniai amidai, kaip kalio kanalų atvėrimo agentai
LTEP19179900.6T LT3567034T (lt)	2017-02-28	2018-02-27	Pentaciklotienilo ir indanilo karbamido dariniai, kaip kalio kanalų atidarytojai

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
LTEP19179900.6T LT3567034T (lt)	2017-02-28	2018-02-27	Pentaciklotienilo ir indanilo karbamido dariniai, kaip kalio kanalų atidarytojai

Country Status (24)

Country	Link
US (2)	US11034665B2 (lt)
EP (3)	EP3366683A1 (lt)
JP (3)	JP6795713B2 (lt)
KR (2)	KR102443685B1 (lt)
CN (2)	CN114105942B (lt)
AU (2)	AU2018227005B2 (lt)
BR (2)	BR112019017184B1 (lt)
CA (2)	CA3238405A1 (lt)
CL (2)	CL2019002445A1 (lt)
CY (2)	CY1123114T1 (lt)
DK (2)	DK3484863T3 (lt)
ES (2)	ES2813064T3 (lt)
HR (2)	HRP20201159T1 (lt)
HU (2)	HUE052703T2 (lt)
IL (1)	IL268931B (lt)
LT (2)	LT3484863T (lt)
MX (2)	MX2019010169A (lt)
PH (1)	PH12019550146A1 (lt)
PL (2)	PL3484863T3 (lt)
PT (2)	PT3484863T (lt)
RS (2)	RS60648B1 (lt)
SI (2)	SI3484863T1 (lt)
WO (1)	WO2018158256A2 (lt)
ZA (1)	ZA201905198B (lt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3366683A1 (en) *	2017-02-28	2018-08-29	Acousia Therapeutics GmbH	Cyclic amides, acteamides and ureas useful as potassium channel openers
US20230136562A1 (en)	2020-04-29	2023-05-04	Idorsia Pharmaceuticals Ltd	Spirourea derivatives
KR20230029813A (ko)	2020-06-25	2023-03-03	이도르시아 파마슈티컬스 리미티드	시클로부틸-우레아 유도체
US20240009149A1 (en) *	2020-11-19	2024-01-11	Acousia Therapeutics Gmbh	Non-aqueous gel composition
EP4279061A1 (en) *	2022-05-18	2023-11-22	Acousia Therapeutics GmbH	Aqueous gel composition

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0594034A (ja)	1990-06-29	1993-04-16	Xerox Corp	クラツクのない電子写真画像形成デバイス
EP0957099B1 (en) *	1998-04-15	2002-11-20	Pfizer Products Inc.	Heterocyclic carboxamides
DE19929076A1 (de)	1999-06-25	2000-12-28	Aventis Pharma Gmbh	Indanylsubstituierte Benzolcarbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE10061876A1 (de) *	2000-12-12	2002-06-20	Aventis Pharma Gmbh	Arylierte Furan- und Thiophencarbonsäureamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
AR033095A1 (es)	2001-04-04	2003-12-03	Wyeth Corp	Metodos para el tratamiento de motilidad gastrica hiperactiva
US7273866B2 (en) *	2002-12-20	2007-09-25	Bristol-Myers Squibb Company	2-aryl thiazole derivatives as KCNQ modulators
AU2004222626B2 (en)	2003-03-21	2010-06-24	H. Lundbeck A/S	Substituted p-diaminobenzene derivatives
TWI349666B (en)	2004-03-12	2011-10-01	Lundbeck & Co As H	Substituted morpholine and thiomorpholine derivatives
UA89503C2 (uk)	2004-09-13	2010-02-10	Х. Луннбек А/С	Заміщені похідні аніліну
US20060188445A1 (en)	2005-02-22	2006-08-24	Fred Hutchinson Cancer Research Center	Assay for compounds that protect against sensory hair cell death and compounds identified by same
US7790770B2 (en) *	2005-11-23	2010-09-07	Bristol-Myers Squibb Company	Heterocyclic CETP inhibitors
WO2007087424A2 (en)	2006-01-25	2007-08-02	The Johns Hopkins University	Method of treating kcnq related disorders using organozinc compounds
WO2007138112A2 (en) *	2006-06-01	2007-12-06	Devgen N.V.	Compounds that interact with ion channels, in particular with ion channels from the kv family
US20090118274A1 (en) *	2007-02-15	2009-05-07	Darin Allen	Monocyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
DE102007032436B4 (de)	2007-07-10	2009-07-16	Heraeus Electro-Nite International N.V.	Vorrichtung zum Sammeln von Gasen in Metallschmelzen
EP2185149A1 (en) *	2007-08-01	2010-05-19	H. Lundbeck A/S	Use of kncq potassium channel openers for reducing symptoms of or treating disorders or conditions wherein the dopaminergic system is disrupted
BRPI0818581A2 (pt)	2007-10-17	2015-07-21	Sanofi Aventis	Carboxamidas n-fenil-bipirrolidina substituídas e uso terapêutico das mesmas
EP2231602A1 (en) *	2007-12-13	2010-09-29	Amgen, Inc	Gamma secretase modulators
US7786171B2 (en) *	2008-04-04	2010-08-31	Abbott Laboratories	Amide derivatives as positive allosteric modulators and methods of use thereof
TW201038572A (en)	2009-03-25	2010-11-01	Gruenenthal Gmbh	Substituted spiro-amide compounds
EP2438037A1 (en) *	2009-06-04	2012-04-11	Merz Pharma GmbH & Co. KGaA	Glycine b antagonists
WO2011085351A2 (en) *	2010-01-11	2011-07-14	The Johns Hopkins University	Method of treating kcnq related disorders
DE102010007281A1 (de) *	2010-02-08	2011-08-11	EMC microcollections GmbH, 72070	Neue Aminoalkyl-oxazol- und Aminoalkyl-thiazolcarbonsäureamide und ihre Anwendung zur Stimulation der endogenen situ Regeneration von Haarsinneszellen im Corti'schen Organ des Innenohres beim Säuger
US8586604B2 (en) *	2010-08-20	2013-11-19	Boehringer Ingelheim International Gmbh	Inhibitors of the microsomal prostaglandin E2 synthase-1
TW201217312A (en) *	2010-09-22	2012-05-01	Gruenenthal Gmbh	Substituted benzamide compounds
ES2656972T3 (es) *	2012-02-23	2018-03-01	Vanderbilt University	Análogos de 5-aminotieno [2,3-c] piridazin-6-carboxamida como moduladores alostéricos positivos del receptor de acetilcolina muscarínico M4
CA2885828C (en)	2012-09-28	2021-04-27	University Of Washington Through Its Center For Commercialization	Ureido-thiophenyl derivatives, compositions thereof and methods for preventing, treating and/or protecting against sensory hair cell death
WO2014079850A1 (en) *	2012-11-23	2014-05-30	F. Hoffmann-La Roche Ag	Substituted heterocyclic derivatives
US9572815B2 (en) *	2013-03-15	2017-02-21	St. Jude Children's Research Hospital	Methods and compositions of p27KIP1 transcriptional modulators
PL404138A1 (pl) *	2013-05-31	2014-12-08	Warszawski Uniwersytet Medyczny	Pochodne kwasu benzoesowego jako inhibitory receptora IL-15Rα
US20150126507A1 (en) *	2013-09-05	2015-05-07	Fate Therapeutics, Inc.	Compounds to treat hearing loss
CA2929194A1 (en) *	2013-11-05	2015-05-14	F. Hoffmann-La Roche Ag	5,6,7,8-tetrahydro-5,8-methanocinnoline derivatives as rorc modulators for the treatment of autoimmune diseases
ES2607752T3 (es) *	2013-11-12	2017-04-03	Acousia Therapeutics Gmbh	Compuestos nuevos para regeneración de células y tejidos terminalmente diferenciados
CN105017085B (zh)	2014-04-28	2018-06-29	中国科学院上海药物研究所	一类kcnq钾通道激动剂、其制备方法和用途
US9493482B2 (en) *	2015-02-06	2016-11-15	University Of Washington	Compounds and methods for preventing or treating sensory hair cell death
GB201601301D0 (en) *	2016-01-25	2016-03-09	Takeda Pharmaceutical	Novel compounds
EP3366683A1 (en) *	2017-02-28	2018-08-29	Acousia Therapeutics GmbH	Cyclic amides, acteamides and ureas useful as potassium channel openers

2017
- 2017-02-28 EP EP17158326.3A patent/EP3366683A1/en not_active Withdrawn
2018
- 2018-02-27 ES ES18707374T patent/ES2813064T3/es active Active
- 2018-02-27 DK DK18707374.7T patent/DK3484863T3/da active
- 2018-02-27 MX MX2019010169A patent/MX2019010169A/es unknown
- 2018-02-27 EP EP18707374.7A patent/EP3484863B1/en active Active
- 2018-02-27 PL PL18707374T patent/PL3484863T3/pl unknown
- 2018-02-27 HU HUE19179900A patent/HUE052703T2/hu unknown
- 2018-02-27 JP JP2019567399A patent/JP6795713B2/ja active Active
- 2018-02-27 SI SI201830113T patent/SI3484863T1/sl unknown
- 2018-02-27 CN CN202111376413.6A patent/CN114105942B/zh active Active
- 2018-02-27 LT LTEP18707374.7T patent/LT3484863T/lt unknown
- 2018-02-27 RS RS20200895A patent/RS60648B1/sr unknown
- 2018-02-27 AU AU2018227005A patent/AU2018227005B2/en active Active
- 2018-02-27 EP EP19179900.6A patent/EP3567034B1/en active Active
- 2018-02-27 CA CA3238405A patent/CA3238405A1/en active Pending
- 2018-02-27 DK DK19179900.6T patent/DK3567034T3/da active
- 2018-02-27 LT LTEP19179900.6T patent/LT3567034T/lt unknown
- 2018-02-27 HU HUE18707374A patent/HUE051854T2/hu unknown
- 2018-02-27 KR KR1020217035304A patent/KR102443685B1/ko active IP Right Grant
- 2018-02-27 SI SI201830189T patent/SI3567034T1/sl unknown
- 2018-02-27 RS RS20201546A patent/RS61254B1/sr unknown
- 2018-02-27 CA CA3052359A patent/CA3052359A1/en active Pending
- 2018-02-27 BR BR112019017184-3A patent/BR112019017184B1/pt active IP Right Grant
- 2018-02-27 WO PCT/EP2018/054820 patent/WO2018158256A2/en active Application Filing
- 2018-02-27 BR BR122020025103-4A patent/BR122020025103B1/pt active IP Right Grant
- 2018-02-27 KR KR1020197023369A patent/KR102382795B1/ko active IP Right Grant
- 2018-02-27 PT PT187073747T patent/PT3484863T/pt unknown
- 2018-02-27 CN CN201880014217.4A patent/CN110312710B/zh active Active
- 2018-02-27 PL PL19179900T patent/PL3567034T3/pl unknown
- 2018-02-27 PT PT191799006T patent/PT3567034T/pt unknown
- 2018-02-27 ES ES19179900T patent/ES2846772T3/es active Active
- 2018-02-27 MX MX2020010866A patent/MX2020010866A/es unknown
- 2018-02-27 US US16/487,933 patent/US11034665B2/en active Active
2019
- 2019-08-06 ZA ZA2019/05198A patent/ZA201905198B/en unknown
- 2019-08-19 PH PH12019550146A patent/PH12019550146A1/en unknown
- 2019-08-26 CL CL2019002445A patent/CL2019002445A1/es unknown
- 2019-08-26 IL IL268931A patent/IL268931B/en unknown
2020
- 2020-07-09 CY CY20201100634T patent/CY1123114T1/el unknown
- 2020-07-23 HR HRP20201159TT patent/HRP20201159T1/hr unknown
- 2020-09-29 JP JP2020163507A patent/JP2021008479A/ja not_active Withdrawn
- 2020-11-09 CY CY20201101052T patent/CY1123488T1/el unknown
- 2020-12-07 HR HRP20201961TT patent/HRP20201961T1/hr unknown
2021
- 2021-05-11 US US17/316,823 patent/US11884642B2/en active Active
- 2021-05-12 CL CL2021001243A patent/CL2021001243A1/es unknown
- 2021-10-22 AU AU2021254653A patent/AU2021254653B2/en active Active
2022
- 2022-08-01 JP JP2022122598A patent/JP7474289B2/ja active Active

Also Published As

Publication number	Publication date
MX2019010169A (es)	2019-10-21
PH12019550146A1 (en)	2020-06-08
EP3484863A2 (en)	2019-05-22
JP7474289B2 (ja)	2024-04-24
CN110312710A (zh)	2019-10-08
RU2019127116A (ru)	2021-03-30
BR112019017184B1 (pt)	2021-06-01
JP2021008479A (ja)	2021-01-28
KR102382795B1 (ko)	2022-04-05
RS61254B1 (sr)	2021-01-29
KR102443685B1 (ko)	2022-09-15
US20200157072A1 (en)	2020-05-21
JP2020510694A (ja)	2020-04-09
DK3484863T3 (da)	2020-09-07
PL3484863T3 (pl)	2020-12-14
CN110312710B (zh)	2022-02-15
HUE051854T2 (hu)	2021-03-29
JP6795713B2 (ja)	2020-12-02
BR122020025103B1 (pt)	2021-06-01
WO2018158256A2 (en)	2018-09-07
CL2019002445A1 (es)	2020-03-13
RU2019127116A3 (lt)	2021-03-31
AU2018227005A1 (en)	2019-08-22
CA3052359A1 (en)	2018-09-07
MX2020010866A (es)	2022-02-28
BR112019017184A2 (pt)	2020-04-28
CL2021001243A1 (es)	2021-10-22
CN114105942A (zh)	2022-03-01
CY1123114T1 (el)	2021-10-29
ES2846772T3 (es)	2021-07-29
ZA201905198B (en)	2020-03-25
SI3567034T1 (sl)	2021-03-31
LT3567034T (lt)	2020-12-10
PT3484863T (pt)	2020-08-27
PT3567034T (pt)	2020-12-04
WO2018158256A3 (en)	2018-12-13
EP3567034B1 (en)	2020-10-28
EP3567034A1 (en)	2019-11-13
IL268931A (en)	2019-10-31
AU2021254653B2 (en)	2022-12-08
HRP20201159T1 (hr)	2020-11-13
AU2018227005B2 (en)	2021-11-11
PL3567034T3 (pl)	2021-05-17
KR20190105058A (ko)	2019-09-11
DK3567034T3 (da)	2021-01-11
CY1123488T1 (el)	2022-03-24
US20210261518A1 (en)	2021-08-26
KR20210134826A (ko)	2021-11-10
CA3238405A1 (en)	2018-09-07
JP2022166055A (ja)	2022-11-01
RS60648B1 (sr)	2020-09-30
ES2813064T3 (es)	2021-03-22
HRP20201961T1 (hr)	2021-02-05
AU2021254653A1 (en)	2021-11-18
EP3484863B1 (en)	2020-06-17
SI3484863T1 (sl)	2020-10-30
HUE052703T2 (hu)	2021-05-28
US11034665B2 (en)	2021-06-15
RU2020140167A (ru)	2020-12-16
CN114105942B (zh)	2024-07-12
IL268931B (en)	2021-10-31
RU2020140167A3 (lt)	2021-04-23
EP3366683A1 (en)	2018-08-29
US11884642B2 (en)	2024-01-30

Publication	Publication Date	Title
IL268799A (en)	2019-10-31	Modified cyclic dinucleotide compounds
HUE051854T2 (hu)	2021-03-29	Gyûrûs amidok mint káliumcsatorna-nyitók
EP3127162A4 (en)	2017-11-22	Germanium tin channel transistors
HK1208424A1 (en)	2016-03-04	Sealing cork
EP3572405B8 (en)	2023-09-06	Benzoimidazol-1,2-yl amides as kv7 channel activators
ZA201703498B (en)	2019-06-26	Kcnq2-5 channel activator
EP3347915A4 (en)	2019-05-08	VERTICAL FIELD EFFECT TRANSISTOR
IL267954B (en)	2022-02-01	potassium channel modulators
EP3314638A4 (en)	2019-05-29	MULTI-HEIGHT FINFET DEVICE THROUGH SELECTIVE OXIDATION
SG11202001568VA (en)	2020-03-30	Extension frame
ZA201800927B (en)	2019-06-26	Split frame
GB201414540D0 (en)	2014-10-01	Nonlinear communication channel
SG10202111437XA (en)	2021-11-29	Cyclic plasmenylethanolamines
GB2566268B (en)	2019-12-04	Channel closure
GB201717786D0 (en)	2017-12-13	Potassium channel inhibitors
GB201711191D0 (en)	2017-08-23	Potassium channel inhibitors
GB201702780D0 (en)	2017-04-05	Capping arrangement
GB201504994D0 (en)	2015-05-06	Multi-use mobility aid device